Clinical trial

Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial…

NCT00152438 · University of British Columbia, Other · Unknown status

Key facts

NCT number NCT00152438
Title Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial Function - Trial of Oral Micronized Progesterone
Official title Vasomotor Symptoms and Endothelial Function-A Randomized Placebo-controlled Trial of Oral Micronized Progesterone (Prometrium®)
Lead sponsor University of British Columbia, Other
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions Menopause
Intervention type Drug, Other
Interventions Oral Micronized Progesterone (Prometrium®), Placebo
Enrollment 125
Start date Sep 1, 2005
Primary completion Oct 1, 2009
Completion Dec 1, 2012
First posted Sep 9, 2005
Last update posted Sep 22, 2011
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies